Successfully Speaking:

How to Prepare Your Best-Ever Presentation

Presented by
Barrett Whitener, IQ Solutions
 Presenter

Barrett Whitener, IQ Solutions

2
 Presenting Your Work:
• The Opportunities
• The Challenges
• The Task

3
 Introduction
The
Hour
Glass
Format
Data

Resolution

4
Take Home Message

• One Full Sentence

• No Definitions

• Synthesis of Conclusion Points

5
Take Home Messages

Some school policies have been effective in improving

dietary intake, but so far their impact on BMI is unclear.

For smokers with medical illnesses, triple-combination

pharmacotherapy is more effective at ending tobacco
dependence than nicotine patch therapy.

Muscle wasting in old age is caused in part by the increasing

rigidity of blood vessels.

6
Preparation Order Presentation Order

1. Take Home Message 1. *

2. Main Question 2. *
3. * 3. Main Question
4. * 4. *
5. * 5. *
6. * 6. Take Home Message
7. * 7. *

7
Main Question

• One Line of Inquiry

• Question Form

• Answered by Take Home Message

8
Main Questions

How effective at reducing obesity are school policies that

set nutritional standards for food sales?

Which is more effective at ending tobacco dependence for

medically ill smokers: pharmacotherapy or nicotine patch
therapy?

What subsystem activity causes muscle weakness in old age?

9
The
Main Question
Data
• Methods
Section • Findings
1.
2.
3.
4.
5.
• Conclusion Points

Take Home Message

10
Selecting Helpful Images

11
 Developmental Brains

GROUP (N) AVG AGE PMI (hrs) pH SEX

Neonate (6) 2 ¾ months 48.4 6.25 4F/2M

Infants (5) 7 months 46.8 6.54 2F/3M

Teenage (8) 16 ½ years 26.5 6.48 8M

Young Adult (6) 22 ½ years 29.1 6.40 6M

Adult (7) 38 ½ years 26.8 6.52 7M

Aged (7) 76 years 45.0 6.26 1F/6M

 Developmental Brains

GROUP (N) AVG AGE PMI (hrs) pH SEX

Neonate (6) 2 ¾ months 48.4 6.25 4F/2M

Infants (5) 7 months 46.8 6.54 2F/3M

Teenage (8) 16 ½ years 26.5 6.48 8M

Young Adult (6) 22 ½ years 29.1 6.40 6M

Adult (7) 38 ½ years 26.8 6.52 7M

Aged (7) 76 years 45.0 6.26 1F/6M

Selecting Helpful Images
• Directed Focus

14
Table1 . Number of wells with elevated arsenic in USA.
State Number of wells by arsenic concentration

10–15 µg/l 16–20 µg/l 20–50 µg/l 50 µg/l+ Total wells

>10 µg/l

Alaska 98 44 104 23 269

Alabama 3 0 2 0 5
Arizona 114 40 80 27 261
California 211 100 165 54 530
Colorado 23 5 17 5 50
Florida 1 0 0 0 1
Idaho 35 17 29 2 83
Illinois 34 20 24 3 81
Indiana 5 1 1 0 7
Kansas 30 3 3 2 38
Kentucky 73 2 4 0 79
Maine 3 6 6 2 20
Michigan 425 255 418 53 1151
Minnesota 61 27 35 3 126
Missouri 8 6 3 0 17
Montana 8 4 5 0 17
North Carolina 53 9 26 6 94
North Dakota 16 8 14 1 39
New Hampshire 52 18 40 12 122
New Jersey 19 6 6 0 31
New Mexico 89 31 44 3 167
Nevada 48 27 57 26 158
Ohio 64 26 17 2 109
Oklahoma 47 21 27 9 104
Oregon 31 10 12 1 54
Texas 89 40 56 8 193
Utah 20 10 13 1 44
All 1663 736 1208 243 3850
 Occurrence of Arsenic in Groundwater

Maximum Contaminant Level in US drinking water: 10 µg/L

Selecting Helpful Images
• Directed Focus

• Visualized Findings

17
 CSSM-Blast Detects More True
Positives Than BLAST
850

800

750
No. of True Positives

700

BLAST

650 CSSM-
BLAST

600

550

500
0 20 40 60 80 100 120

No. of False Positives

 True vs. False Positives:
BLAST v. CSSM-BLAST
850

800
No. of True Positives

750

700

650
BLAST
CSSM-BLAST
600

550

500
0 10 20 30 40 50 60 70 80 90 100

No. of False Positives

Selecting Helpful Images
• Directed Focus
• Visualized Findings
• High Contrast

20
Selecting Helpful Images
• Directed Focus
• Visualized Findings
• High Contrast
• Title as Label

21
 NIH Spending by Disease

600

500

400
Millions of Dollars

300 Lung Cancer

200

100

0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Year
 NIH Spending by Disease

600

500

400
Millions of Dollars

Prostate Cancer
300
Lung Cancer

200

100

0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Year
 NIH Spending by Disease

600

500

400
Millions of Dollars

Breast Cancer
300 Prostate Cancer
Lung Cancer

200

100

0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Year
Selecting Helpful Images
• Directed Focus
• Visualized Findings
• High Contrast
• Title as Label
• “On the Same Page”

25
 Myosin II function Assay in Dictyostelium Cells
Growth Rate in Suspension Culture DAPI Stain Nuclei

Mutant
Cell Density (cells/ml)

WT
WT
107

106
Mutant

105
0 1 2 3 4 5 6
Time (days)

Development
WT Mutant
 DAPI Stain Nuclei

WT Mutant

Single nucleus Multi-nuclei

Small size Big size
Selecting Helpful Images
• Directed Focus
• Visualized Findings
• High Contrast
• Title as Label
• “On the Same Page”
• Money Slide

28
Preparation Order Presentation Order

1. Take Home Message 1. *

2. Main Question 2. *
3. Money Slide 3. Main Question
4. * 4. Money Slide
5. * 5. *
6. * 6. Take Home Message
7. * 7. *

29
Preparation Order Presentation Order

1. Take Home Message 1. *

2. Main Question 2. *
3. Money Slide 3. Main Question
4. Supporting Slides 4. Money Slide
5. * 5. Supporting Slides
6. * 6. Take Home Message
7. * 7. *

30
 Conclusions

• In children with BMI between 21.7 and 22.9 and average age of
10.49, antioxidants decreased by an average 3 points for each
percentage-point increase in BMI; this result may differ in
cases of severe obesity
• The platelet fatty acid profile appeared to be independent of
BMI percentage shifts; this relationship needs to be further
examined
• Stearic acid levels decreased by an average of 12 points for
each percentage-point decrease in BMI; this contrasts with
previous findings of 18 percent
• Applying the Artificial Neural Network Map (ANN), these
findings could account for the high risk of depression among
obese children, as well as their lower risk for ischemia

31
 Conclusions

• Antioxidants and BMI

32
 Conclusions

• Antioxidants and BMI

• Platelet Fatty Acids and BMI

33
 Conclusions

• Antioxidants and BMI

• Platelet Fatty Acids and BMI

• Stearic Acid and BMI

34
 Conclusions

• Antioxidants and BMI

• Platelet Fatty Acids and BMI

• Stearic Acid and BMI

• Implications for Depression and
Ischemia

35
Selecting Helpful Images
• Directed Focus
• Visualized Findings
• High Contrast
• Title as Label
• “On the Same Page”
• Money Slide
• Minimal Text

36
The
Common Ground
Introduction

(Background)

Main Question

37
 The Introduction

Common Ground

1. What issue/challenge is the audience

confronting in its work?
2. What specific aspect of the problem does
your project address?

3. How are you analyzing

the problem and why are
you using this
approach?
4. (Main Question)
Preparation Order Presentation Order

1. Take Home Message 1. *

2. Main Question 2. Common Ground
3. Money Slide 3. Main Question
4. Supporting Slides 4. Money Slide
5. Common Ground 5. Supporting Slides
6. * 6. Take Home Message
7. * 7. *

39
The Resolution

Take Home Message

Future Directions

Exit Line

40
Preparation Order Presentation Order

1. Take Home Message 1. *

2. Main Question 2. Common Ground
3. Money Slide 3. Main Question
4. Supporting Slides 4. Money Slide
5. Common Ground 5. Supporting Slides
6. Exit Line 6. Take Home Message
7. * 7. Exit Line

41
Preparation Order Presentation Order

1. Take Home Message 1. Title

2. Main Question 2. Common Ground
3. Money Slide 3. Main Question
4. Supporting Slides 4. Money Slide
5. Common Ground 5. Supporting Slides
6. Exit Line 6. Take Home Message
7. Title 7. Exit Line

42
Title
• Brief (8 to 10 words)
• Main-Question Orientation

43
Prenatal Risk Factors
Contribute to Racial/Ethnic
Differences in Childhood
Obesity

44
Racial/Ethnic Differences in
Childhood Obesity:
Identifying Key Risk Factors

45
Title
• Brief (8 to 10 words)
• Main-Question Orientation
• Implication in Main Title
• Detail in Sub-Title

46
Delay of Epiphyseal Fusion:
An Experimental Approach for
Increasing the Height of
Extremely Short Children

47
Increasing the Height of Short
Children:
Delay of Epiphyseal Fusion

48
 (Title)
Common Ground
Introduction
The
Hour
Main Question
Glass
Format
Money Slide
Data Supporting Slides

Take Home Message

Resolution
Exit Line

49
Your Questions

50
To Receive Feedback on Your Presentation:

humancapital@iqsolutions.com

51
Successfully Speaking:
How to Prepare Your Best-Ever Presentation

Presented by
Barrett Whitener, IQ Solutions